Clinical Trials Directory

Trials / Completed

CompletedNCT05181007

Drug-drug Interaction Between Ciprofol and Mefanamic Acid or Valproate

An Open-label, Two-stage Study Evaluating Drug-drug Interaction Between Ciprofol Injectable Emulsion and Mefanamic Acid or Valproate in Healthy Volunteers

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
41 (actual)
Sponsor
Haisco Pharmaceutical Group Co., Ltd. · Industry
Sex
All
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

study the effect of mefanamic acid or valproate on ciprofol

Conditions

Interventions

TypeNameDescription
DRUGMefanamic Acidmefanamic acid once every 6 hours on Day 4 and Day 5, Ciprofol on Day 1 and Day 5
DRUGValproatevalproate once daily on Day 4 to Day 8, Ciprofol on Day 1 and Day 8

Timeline

Start date
2021-12-17
Primary completion
2022-03-23
Completion
2022-06-01
First posted
2022-01-06
Last updated
2022-07-14

Locations

1 site across 1 country: China

Regulatory

Source: ClinicalTrials.gov record NCT05181007. Inclusion in this directory is not an endorsement.